OPKO Health
OPK
#6210
Rank
A$1.47 B
Marketcap
A$1.97
Share price
0.73%
Change (1 day)
-15.32%
Change (1 year)

Earnings for OPKO Health (OPK)

Earnings in 2026 (TTM): -A$0.12 Billion

According to OPKO Health 's latest financial reports the company's current earnings are A$0.58 Billion. In 2025 the company made an earning of -A$0.35 Billion a decrease over its 2024 earnings that were of -A$14.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OPKO Health from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.12 Billion-66.76%
2025 -A$0.35 Billion2229.09%
2024 -A$14.84 Million-94.38%
2023 -A$0.27 Billion-52.92%
2022 -A$0.57 Billion2691.58%
2021 -A$20.08 Million-128.81%
2020 A$69.67 M-115.96%
2019 -A$0.44 Billion72.03%
2018 -A$0.26 Billion-33.83%
2017 -A$0.39 Billion264.29%
2016 -A$0.11 Billion-46.71%
2015 -A$0.2 Billion-19.31%
2014 -A$0.25 Billion64.11%
2013 -A$0.15 Billion180.06%
2012 -A$53.26 Million53.56%
2011 -A$34.69 Million55.87%
2010 -A$22.26 Million-48.27%
2009 -A$43.02 Million-24.64%
2008 -A$57.07 Million-85.11%
2007 -A$0.39 Billion6.61%
2006 -A$0.36 Billion18539.02%
2005 -A$1.93 Million-32.33%
2004 -A$2.86 Million-45.53%
2003 -A$5.24 Million-64.7%
2002 -A$14.83 Million2.99%
2001 -A$14.4 Million16.9%
2000 -A$12.32 Million104.81%
1999 -A$6.02 Million40.03%
1998 -A$4.3 Million-0%
1997 -A$4.3 Million7.14%
1996 -A$4.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.50 B-32,931.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.64 B-10,293.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.39 B-6,571.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.04 B-15,020.14%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$2.09 B-1,930.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.60 B-1,508.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.29 B-2,110.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-A$79.4 Million-30.50%๐Ÿ‡บ๐Ÿ‡ธ USA